Molecular Imaging

In a new review from the European Society of Urogenital Radiology (ESUR), researchers discuss the merits and limitations of PSMA PET/CT and whole-body MRI (WB-MRI) for patients with advanced prostate cancer.

Expanded capabilities for the Sirona Advanced Imaging Suite reportedly include quantitative SUV analysis and multiplanar reconstruction for PET/CT imaging.

Catch up on the most-well viewed prostate cancer imaging content in October 2025.

Pluvicto in combination with the standard of care led to a 28 percent reduction in the risk of radiographic progression or death in patients with metastatic hormone-sensitive prostate cancer (mHSPC), according to results from the phase III PSMAddition trial presented at the European Society for Medical Oncology (ESMO) conference.

In the 160-patient study comparing 18F-PSMA 1007 PET/CT and 18F-NaF PET/CT, the use of 18F-PSMA PET/CT led to 38 patients being restaged as having more advanced prostate cancer.

Catch up on the top radiology content of the past week.

In a recent interview, Emmanuel S. Antonarakis, M.D. discussed contributing factors to the recent American Cancer Society report about rising prostate cancer incidence and offered insights about the potential role of the radioligand agent 177Lu-PSMA-I&T for patients with mCRPC.

Catch up on the most-well viewed radiology content in September 2025.

Catch up on the top radiology content of the past week.

The combination of digital breast tomosynthesis (DBT) and molecular breast imaging (MBI) offered more than double the detection of invasive breast cancer with DBT in the first year of screening, according to a prospective study of nearly 3,000 women with dense breasts.

PSMA PET offered 18 percent higher accuracy for detecting biochemical recurrence of PCa in contrast to mpMRI, according to findings from a 67-study meta-analysis.

Catch up on the top radiology content of the past week.

Issued by multiple societies, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the new guidelines for utilizing 18F-flurpiridaz-PET myocardial perfusion imaging (MPI) offer insights on proper patient selection, appropriate protocols and salient keys for image interpretation.

Preliminary research findings have shown that the investigational anti-microtubule binding region (MTBR) tau antibody etalanetug may help reduce a biomarker for brain tau pathophysiology and tau signals on positron emission tomography (PET).

Catch up on the top radiology content of the past week.

The latest edition of the Hermia software reportedly facilitates standard evaluation of amyloid PET quantification across a variety of tracers and protocols.

New research shows that over 94 percent of patients who had a PSA level of < 0.2 ng/mL and low-volume disease assessment six months after initiation of apalutamide and androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer had radiographic progression-free survival at 24 months.

Featuring advanced detector technology, the Pharos PET scanner reportedly enhances detection of subtle anomalies across brain, breast and extremity imaging.

Catch up on the most-well viewed radiology content in August 2025.

Catch up on the most-well viewed prostate imaging content in August 2025.

Catch up on the latest news, research and insights in radiology with our Weekly Scan.

Catch up on the top radiology content of the past week.

Patient with biochemical recurrence of prostate cancer who had PSMA PET/CT prior to salvage radiotherapy had better survival rates at one, two and five years, according to newly published research.

The iPETcertum software reportedly provides automated segmentation and enhanced visualization of regions of interest on PET scans with a single click.

Catch up on the top radiology content of the past week.